Abbott Laboratories (ABT) Dividends payables (2009 - 2026)

Abbott Laboratories' Dividends payables history runs 18 years deep, the most recent figure standing at $1.1 billion for Q1 2026.

• In Q1 2026, Dividends payables rose 6.59% year-over-year to $1.1 billion; the TTM figure through Mar 2026 stood at $1.1 billion (up 6.59% YoY), while the FY2025 annual figure was $1.1 billion, up 7.13% from the prior year.
• Dividends payables came in at $1.1 billion for Q1 2026 at Abbott Laboratories, roughly flat from $1.1 billion in the prior quarter.
• In the past five years, Dividends payables ranged from a high of $1.1 billion in Q1 2026 to a low of $820.0 million in Q3 2022.
• A 5-year average of $950.4 million and a median of $956.0 million in 2024 frame the typical range for Dividends payables.
• Across the five-year window, Dividends payables climbed 2.87% in 2022 and gained 8.24% in 2024, its largest moves.
• Abbott Laboratories' Dividends payables stood at $887.0 million in 2022, then rose by 7.67% to $955.0 million in 2023, then rose by 7.23% to $1.0 billion in 2024, then increased by 7.13% to $1.1 billion in 2025, then gained by 0.27% to $1.1 billion in 2026.
• According to Business Quant data, Dividends payables over the past three periods registered $1.1 billion, $1.1 billion, and $1.0 billion for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison